6
Oct
2026

ANEMOCYTE

Exhibitor at CPHI Milan 2026 stand 9H128, Contamination Control
About Us

Anemocyte, a Biotech Manufacturing Organization based in Italy, offers development and manufacturing services and innovative solutions from R&D to GMP to address needs in the field of: - pDNA - Plasmids for Viral Vector and RNA manufacturing; - mRNA ' mRNA manufacturing for Vaccines and Therapies. Our experience: > 20 years of manufacturing innovative Therapies. Meet us at the Bio Production zone at booth #3D105!

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Italy
  • On CPHI since:
    2018
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
Other
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 9H128, Contamination Control

Products Featured at CPHI Milan 2026

  • mRNA

    Product mRNA

    mRNA can be used for: - Vaccines; - Immuno-oncology therapies; - Protein replacement therapies; - Genetic diseases. MANUFACTURING Highlights Starting from 1 mL batch size QUALITY Highlights - Production and analysis are performed in ISO certified laboratories; - All the equipment for production and anal...
  • Cell therapy manufacturing

    Product Cell therapy manufacturing

    Development, optimization and GMP manufacturing of cell therapy products. 

    Manufacturing Highlights:

    • Manufacturing of autologous and allogeneic cell therapy products.• Non-viral gene modification.
    • Process an...
  • Plasmid DNA

    Product Plasmid DNA

    Manufacturing of plasmid DNA as starting material for:

    • Clinical manufacturing of gene and immuno-oncology therapies, for example in AAV or lentiviral vector.
    • Clinical manufacturing of biological drugs.

    Quality Highlights:
    ...